VISTA
Dec 07, 2023•15 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Our Landmarks of OncoPharm series returns to talk about 2008's VISTA study, which ushered bortezomib into the front line setting, albeit with a now outdated alkylating agent-based backbone.
VISTA (VMP vs. MP): https://www.nejm.org/doi/full/10.1056/nejmoa0801479
For the best experience, listen in Metacast app for iOS or Android